Concepedia

Jonathan Kil

JK

16

Publications

1.8K

Citations

16

H-Index

1993

Active since

Affiliations

University of California, Irvine(Current)

SciClone Pharmaceuticals (United States)

Rosetta Stone (United States)

Jonathan Kil is an author at University of California, Irvine specializing in medicine, health sciences, and pharmacology.

Top concepts

Publications per year

1993–2020

16

Publications

16

Gene disruption of p27 <sup>Kip1</sup> allows cell proliferation in the postnatal and adult organ of Corti

Hubert Löwenheim, David N. Furness, Jonathan Kil et al. · Proceedings of the National Academy of Sciences · 1999 · 365 citations · Full text

Safety and efficacy of ebselen for the prevention of noise-induced hearing loss: a randomised, double-blind, placebo-controlled, phase 2 trial

Jonathan Kil, Edward Lobariñas, Christopher Spankovich et al. · The Lancet · 2017 · 255 citations

, , +9

Juvenile Antioxidant Treatment Prevents Adult Deficits in a Developmental Model of Schizophrenia

Jan-Harry Cabungcal, Danielle S. Counotte, Eastman M. Lewis et al. · Neuron · 2014 · 194 citations · Full text

, , +7

Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen

Eric D. Lynch, Rende Gu, Carol Pierce et al. · Hearing Research · 2004 · 167 citations

, , +8

Ebselen treatment reduces noise induced hearing loss via the mimicry and induction of glutathione peroxidase

Jonathan Kil, Carol Pierce, Huy Tran et al. · Hearing Research · 2006 · 137 citations

, , +12

Rows per page

1–5 of 16